A Multi-center Prospective Cohort Study of Benign Breast Disease and Risk of Subsequent Breast Cancer

Overview

Journal Cancer Causes Control

Specialties Oncology
Public Health

Date 2010 Jan 20

PMID 20084540

Citations 44

Authors

Geoffrey C Kabat

Joan G Jones

Neal Olson

Abdissa Negassa

Catherine Duggan

Mindy Ginsberg

Rita A Kandel

Andrew G Glass

Thomas E Rohan

Affiliations

Soon will be listed here.

Abstract

Objective: We used a nested case-control design within a large, multi-center cohort of women who underwent a biopsy for benign breast disease (BBD) to assess the association of broad histologic groupings and specific histologic entities with risk of breast cancer.

Methods: Cases were all women who had a biopsy for BBD and who subsequently developed breast cancer; controls were individually matched to cases and were women with a biopsy for BBD who did not develop breast cancer in the same follow-up interval as that for the cases. After exclusions, 1,239 records (615 cases and 624 controls) were available for analysis. We used conditional logistic regression to estimate odds ratios and 95% confidence intervals (CIs).

Results: Relative to non-proliferative BBD/normal pathology, the multivariable-adjusted odds ratio for proliferative lesions without atypia was 1.45 (95% CI 1.10-1.90), and that for atypical hyperplasia was 5.27 (95% CI 2.29-12.15). The presence of multiple foci of columnar cell hyperplasia and of complex fibroadenoma without atypia was associated with a non-significantly increased risk of breast cancer, whereas sclerosing adenosis, radial scar, and papilloma showed no association with risk.

Conclusion: Our results indicate that, compared to women with normal pathology/non-proliferative disease, women with proliferative disease without atypia have a modestly increased risk of breast cancer, whereas women with atypical hyperplasia have a substantially increased risk.

Citing Articles

A systematic review of determinants of breast cancer risk among women with benign breast disease.

Burke A, ODriscoll J, Abubakar M, Bennett K, Carmody E, Flanagan F NPJ Breast Cancer. 2025; 11(1):16.

PMID: 39955290 PMC: 11829998. DOI: 10.1038/s41523-024-00703-w.

Changes in breast cancer risk associated with benign breast disease from 1967 to 2013.

Degnim A, Ghosh K, Vierkant R, Winham S, Hoskin T, Carter J JNCI Cancer Spectr. 2025; 9(1).

PMID: 39786446 PMC: 11770946. DOI: 10.1093/jncics/pkae128.

Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.

Limberg J, Thomas S, Dalton J, Ntowe K, Nash A, Chiba A Ann Surg Oncol. 2024; 31(11):7550-7558.

PMID: 39034366 PMC: 11472765. DOI: 10.1245/s10434-024-15788-7.

Multiplicity of benign breast disease lesions and breast cancer risk in African American women.

Patil V, Ruterbusch J, Chen W, Boerner J, Abdulfatah E, Alosh B Front Oncol. 2024; 14:1410819.

PMID: 38817898 PMC: 11137188. DOI: 10.3389/fonc.2024.1410819.

Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk.

Song J, Jang J, Kang K, Jung J, Kim C, Kim A Breast J. 2024; 2023:9117047.

PMID: 38178922 PMC: 10764649. DOI: 10.1155/2023/9117047.

References

Rohan T, Hartwick W, Miller A, Kandel R . Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. J Natl Cancer Inst. 1998; 90(17):1262-9. DOI: 10.1093/jnci/90.17.1262. View

Patterson J, Scott M, Anderson N, Kirk S . Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol. 2004; 30(10):1065-8. DOI: 10.1016/j.ejso.2004.08.004. View

Carter C, Corle D, Micozzi M, Schatzkin A, Taylor P . A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol. 1988; 128(3):467-77. DOI: 10.1093/oxfordjournals.aje.a114995. View

Jacobs T, Byrne C, Colditz G, Connolly J, Schnitt S . Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 1999; 340(6):430-6. DOI: 10.1056/NEJM199902113400604. View

Ashbeck E, Rosenberg R, Stauber P, Key C . Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(3):467-72. DOI: 10.1158/1055-9965.EPI-06-0394. View

Sanders M, Page D, Simpson J, Schuyler P, Plummer W, Dupont W . Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer. 2006; 106(7):1453-61. DOI: 10.1002/cncr.21730. View

Hartmann L, Sellers T, Frost M, Lingle W, Degnim A, Ghosh K . Benign breast disease and the risk of breast cancer. N Engl J Med. 2005; 353(3):229-37. DOI: 10.1056/NEJMoa044383. View

Berg J, Visscher D, Vierkant R, Pankratz V, Maloney S, Lewis J . Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008; 108(2):167-74. DOI: 10.1007/s10549-007-9605-9. View

Boulos F, Dupont W, Simpson J, Schuyler P, Sanders M, Freudenthal M . Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer. 2008; 113(9):2415-21. PMC: 3121952. DOI: 10.1002/cncr.23873. View

10.

Bodian C . Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev. 1993; 15(1):177-87. DOI: 10.1093/oxfordjournals.epirev.a036103. View

11.

Lewis J, Hartmann L, Vierkant R, Maloney S, Pankratz V, Allers T . An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006; 30(6):665-72. DOI: 10.1097/00000478-200606000-00001. View

12.

Fitzgibbons P, Henson D, HUTTER R . Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998; 122(12):1053-5. View

13.

Schnitt S . Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003; 27(6):836-41. DOI: 10.1097/00000478-200306000-00017. View

14.

Shaaban A, Sloane J, West C, Moore F, Jarvis C, Williams E . Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002; 26(4):421-30. DOI: 10.1097/00000478-200204000-00003. View

15.

Dupont W, Page D, Parl F, Vnencak-Jones C, Plummer Jr W, Rados M . Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994; 331(1):10-5. DOI: 10.1056/NEJM199407073310103. View

16.

Krieger N, Hiatt R . Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol. 1992; 135(6):619-31. DOI: 10.1093/oxfordjournals.aje.a116341. View

17.

Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S . Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2006; 109(2):180-7. DOI: 10.1002/cncr.22408. View

18.

Page D, Dupont W, Rogers L, Rados M . Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985; 55(11):2698-708. DOI: 10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a. View

19.

King T, Scharfenberg J, Smetherman D, Farkas E, Bolton J, Fuhrman G . A better understanding of the term radial scar. Am J Surg. 2001; 180(6):428-32; discussion 432-3. DOI: 10.1016/s0002-9610(00)00506-7. View

20.

Degnim A, Visscher D, Berman H, Frost M, Sellers T, Vierkant R . Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007; 25(19):2671-7. DOI: 10.1200/JCO.2006.09.0217. View